Study Group: Formulary Design Experts

Council Members in this Study Group: 259

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Samir Mehta

Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Samir Mehta, MD, is Orthopaedic Surgeon at the Hospital of the University of Pennsylvania. Previously, Dr. Mehta was Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of Pennsylvania....

1 event(s)
David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.David Zimmerman

President/Owner
Doctors of Pharmacy, Inc.
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at EHIM, a pharmacy benefit manager. He has over 30 years of experience, specializing...

10 news post(s)
B. Michael Silber, Chief of Drug Discovery R&D and Professor, University of California, San Francisco - CCB. Michael Silber

Chief of Drug Discovery R&D and Professor
University of California, San Francisco - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Michael Silber, PhD, is Professor of Neurology, Bioengineering and Therapeutic Sciences, and Chief of Drug Discovery R & D, at the Institute for Neurodegenerative Diseases, UCSF School of Medicine. He has 25 years of experience as a senior leader in Pharma...

Keith Berman, Consultant, HEALTH RESEARCH ASSOCIATESKeith Berman

Consultant
HEALTH RESEARCH ASSOCIATES
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Keith Berman, MPH, MBA, founded Health Research Associates in 1996. HRA provides reimbursement consulting, business development and market research services to leading biopharmaceuticals, blood products and medical device manufacturers and suppliers....

35 news post(s)
1 event(s)
Bruce Goldberg, Pharmacist, KOHLL'S PHARMACY & HOMECARE, INCBruce Goldberg

Pharmacist
KOHLL'S PHARMACY & HOMECARE, INC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Bruce Goldberg is a pharmacist with Kohll's Pharmacy and Homecare in Omaha, Nebraska, where he works in the managed care division with payer groups, insurers, and the general public on methods to reign in prescription drug costs. He is the past president...

4 news post(s)

View all Leading Experts in this Study Group

Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Consultancy, Healthcare-Focused
  • Facility, Academic Medical Center
  • Managed Care Health Insurer, For-Profit
  • Non-Academic Community Hospital or Clinic
  • Facility, Non-Academic/Community Hospital
  • Managed Care Health Insurer, Non-Profit
  • Office Based Private Practice or Clinic
  • Facility, Government/Public Hospital
  • Pharmaceutical Benefits Manager, Large >10 M Lives
  • Pharmaceuticals Manufacturer
  • Academic Institution*
  • Consultancy, Pharma-Focused
  • Pharmacy or Drug Store, Independent/Local

Members in this Study Group often have these job titles:

  • Pharmacist - RPh/PharmD
  • Director
  • Physician - Attending Physician
  • President
  • Consultant
  • Physician - Director
  • Manager
  • Chief Executive Officer
  • Owner

Related Study Groups

Study Group Name No. Members
Physicians who Treat Asthma (US) 679
Methotrexate Prescribers (US) 40
Pharmacists in Germany 16
Gouty Arthritis Specialists (US) 140
Pricing Trend Experts on Spinal Implants 25
Surgeons who Perform Spinal Fusions 133
Prograf Prescribers 19
Distributors of Durable Medical Equipments 50

GLG Live Meetings with this Study Group's Leading Experts (?)

March 19, 2008 | Boston

GLGi: Orthopedics

July 31, 2007 | Boston

GLGi: Managed Care Formulary

July 30, 2007 | New York

GLGi: Managed Care Formulary

Teleconference: Grifols/Talecris - Competitive Implications (11:00 AM EDT/ 16:00 BST)

6/9/2010